SCHEMBL17019481

SCHEMBL17019481

c1ccc(-c2ccc3c(-c4ccc(-c5ccccn5)nc4)c4ccccc4c(-c4ccc(-c5cccnc5)nc4)c3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.56
PIM1 P11309 3/20 0.46
PIM2 Q9P1W9 2/20 0.46
CYP19A1 P11511 2/20 0.43
CYP3A4 P08684 2/20 0.43
HPGDS O60760 1/20 0.42
PIM3 Q86V86 1/20 0.41
DHODH Q02127 2/20 0.41
SCN5A Q14524 1/20 0.41
SCN9A Q15858 1/20 0.41
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP11B1 P15538 3/20 0.39
CYP11B2 P19099 3/20 0.39
GRM5 P41594 1/20 0.39
KMO O15229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17463152 1.00 CYP2A6 (0.56) CYP2A6PIM1PIM2CYP19A1CYP3A4
SCHEMBL17589453 0.98 CYP2A6 (0.56) CYP2A6PIM1PIM2CYP19A1CYP3A4
SCHEMBL2022016 0.94 CYP19A1 (0.49) CYP2A6PIM1PIM2CYP19A1CYP3A4
SCHEMBL17342842 0.92 HPGDS (0.46) CYP2A6PIM1PIM2HPGDSDHODH
SCHEMBL17737597 0.92 HPGDS (0.46) CYP2A6PIM1PIM2HPGDSDHODH
SCHEMBL11886867 0.92 CYP19A1 (0.48) CYP2A6PIM1PIM2CYP19A1CYP3A4
SCHEMBL23344747 0.91 HPGDS (0.47) CYP2A6PIM1HPGDSDHODHNPC1
SCHEMBL24106243 0.91 HPGDS (0.47) CYP2A6PIM1HPGDSDHODHNPC1
SCHEMBL30779191 0.91 HPGDS (0.49) CYP2A6PIM1PIM2HPGDSDHODH
SCHEMBL4951058 0.91 HPGDS (0.49) CYP2A6PIM1PIM2HPGDSDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329103-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 US disclosed
US-20230329103-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 US disclosed
US-20200328351-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2020-10-15 US disclosed
US-10333077-B2 Organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-06-25 US disclosed
US-20170186975-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-29 US disclosed
US-20170186975-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-29 US disclosed
US-20150236262-A1 ORGANIC LIGHT-EMITTING DEVICES SAMSUNG DISPLAY CO., LTD (KR) 2015-08-20 US disclosed
US-20150236262-A1 ORGANIC LIGHT-EMITTING DEVICES SAMSUNG DISPLAY CO., LTD (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200328351-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, MCM5, CCNL2 CYP2A6 2859/4885PIM1 2639/4885PIM2 2839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.